Patented TechnologyPsychemedics' patented hair testing technology provides a competitive advantage by offering a longer detection window, enhancing its market position in drug testing.

Debt ManagementImproved debt management reduces financial risk and enhances the company's ability to invest in growth opportunities, supporting long-term stability.

Cash Flow ImprovementPositive cash flow indicates better financial health, enabling Psychemedics to fund operations and potential expansions without relying on external financing.

Bears Say

Declining RevenuesPersistent revenue decline suggests challenges in market demand or competition, which could impact long-term growth and profitability.

Negative Profit MarginsNegative profit margins highlight ongoing operational inefficiencies and could limit the company's ability to reinvest in business growth.

Operational ChallengesNegative EBIT and EBITDA margins indicate operational inefficiencies, which may hinder the company's ability to achieve sustainable profitability.

Psychemedics News

Psychemedics Corporation: Navigating Challenges in Drug Testing

Psychemedics ( ($PMDI) ) has released its Q4 earnings. Here is a breakdown of the information Psychemedics presented...

11M ago

PMDI

PMDI FAQ

What was Psychemedics’s price range in the past 12 months?

Psychemedics lowest stock price was $1.45 and its highest was $2.50 in the past 12 months.

What is Psychemedics’s market cap?

Psychemedics’s market cap is $9.18M.

When is Psychemedics’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Psychemedics’s earnings last quarter?

Currently, no data Available

Is Psychemedics overvalued?

According to Wall Street analysts Psychemedics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Psychemedics pay dividends?

Psychemedics does not currently pay dividends.

What is Psychemedics’s EPS estimate?

Psychemedics’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Psychemedics have?

Psychemedics has 6,119,477 shares outstanding.

What happened to Psychemedics’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Psychemedics?

Currently, no hedge funds are holding shares in PMDI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Psychemedics

Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. It offers workplace, school, and personal drug testing services. The company was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.